Moderna Inc. Stock Climbs 8.5%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. advanced 8.5% to $158.07 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.7% to 26,418.30 and the Dow Jones Industrial Average rising 0.6% to 51,778.04.

This was the stock's second consecutive day of gains.

Moderna Inc. closed 10.5% short of its 52-week high of $176.66, which the company reached on August 19th.

The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.22, Pfizer Inc. rose 0.7% to $27.64, and Gilead Sciences Inc. rose 2.17% to $150.89.

Trading volume totaled 19.1 million, compared to the 50-day average of 17.3 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 17, 2026 16:33 ET (20:33 GMT)